Over 70% of small-molecule therapeutics emerging from today's discovery pipelines are too poorly water-soluble to enable adequate bioavailability after oral intake. This solubility problem greatly hinders pharmaceutical development and ultimately prevents patients from accessing potentially life-saving treatments.
At Harpago, we tackle this solubility problem through rigorous formulation design and development. Our dosage forms are being used by pharmaceutical companies across the globe to enhance solubility and bioavailability in discovery, preclinical and early clinical projects.
To support the expansion of our labs in Ghent, Belgium, we are interested in attracting both experienced and junior staff. If you want to take part in tackling one of the greatest challenges the pharmaceutical industry is faced with today, one of our job openings may be for you.